Market News

$-0.31 EPS Expected for Forterra, Inc. (FRTA)

Analysts expect Forterra, Inc. (NASDAQ:FRTA) to report $-0.31 EPS on March, 6.They anticipate $0.03 EPS change or 10.71 % from last quarter’s $-0.28 EPS. After having $0.09 EPS previously, Forterra, Inc.’s analysts see -444.44 % EPS growth. The stock increased 4.20% or $0.23 during the last trading session, reaching $5.7. […]

Second Sight Medical Products, Inc. (EYES) EPS Estimated At $-0.11

Second Sight Medical Products, Inc. (EYES) EPS Estimated At $-0.11

Analysts expect Second Sight Medical Products, Inc. (NASDAQ:EYES) to report $-0.11 EPS on March, 6.They anticipate $0.05 EPS change or 31.25 % from last quarter’s $-0.16 EPS. After having $-0.12 EPS previously, Second Sight Medical Products, Inc.’s analysts see -8.33 % EPS growth. The stock increased 1.80% or $0.0131 during […]

Evoke Pharma, Inc. (EVOK) EPS Estimated At $-0.10

Evoke Pharma, Inc. (EVOK) EPS Estimated At $-0.10

Investors sentiment increased to 2.33 in Q3 2018. Its up 0.66, from 1.67 in 2018Q2. It is positive, as 2 investors sold Evoke Pharma, Inc. shares while 1 reduced holdings. 5 funds opened positions while 2 raised stakes. 3.19 million shares or 2.68% more from 3.11 million shares in 2018Q2 […]

Energy Recovery, Inc. (ERII) EPS Estimated At $0.01

Energy Recovery, Inc. (ERII) EPS Estimated At $0.01

Investors sentiment decreased to 0.98 in 2018 Q3. Its down 0.05, from 1.03 in 2018Q2. It is negative, as 7 investors sold Energy Recovery, Inc. shares while 33 reduced holdings. 13 funds opened positions while 26 raised stakes. 16.68 million shares or 6.76% less from 17.89 million shares in 2018Q2 […]

EPS for Crawford & Company (CRD.B) Expected At $0.24

EPS for Crawford & Company (CRD.B) Expected At $0.24

Analysts expect Crawford & Company (NYSE:CRD.B) to report $0.24 EPS on March, 6.They anticipate $0.04 EPS change or 14.29 % from last quarter’s $0.28 EPS. CRD_B’s profit would be $12.66 million giving it 10.86 P/E if the $0.24 EPS is correct. After having $0.15 EPS previously, Crawford & Company’s analysts […]

$-0.36 EPS Expected for Collegium Pharmaceutical, Inc. (COLL)

$-0.36 EPS Expected for Collegium Pharmaceutical, Inc. (COLL)

Analysts expect Collegium Pharmaceutical, Inc. (NASDAQ:COLL) to report $-0.36 EPS on March, 6.They anticipate $0.18 EPS change or 33.33 % from last quarter’s $-0.54 EPS. After having $-0.50 EPS previously, Collegium Pharmaceutical, Inc.’s analysts see -28.00 % EPS growth. The stock increased 1.69% or $0.25 during the last trading session, […]

Analysts See $-0.08 EPS for Celldex Therapeutics, Inc. (CLDX)

Analysts See $-0.08 EPS for Celldex Therapeutics, Inc. (CLDX)

Analysts expect Celldex Therapeutics, Inc. (NASDAQ:CLDX) to report $-0.08 EPS on March, 6.They anticipate $0.09 EPS change or 52.94 % from last quarter’s $-0.17 EPS. After having $-0.08 EPS previously, Celldex Therapeutics, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 1.19% or $0.07 during the last trading session, […]

Dynex Capital (NYSE:DX) Shares Were Downgraded Today by BidaskScore

Dynex Capital (NYSE:DX) Shares Were Downgraded Today by BidaskScore

Investors sentiment decreased to 1.28 in 2018 Q3. Its down 0.40, from 1.68 in 2018Q2. It worsened, as 14 investors sold Dynex Capital, Inc. shares while 26 reduced holdings. 14 funds opened positions while 37 raised stakes. 27.34 million shares or 1.97% more from 26.81 million shares in 2018Q2 were […]

Blueknight Energy Partners, L.P. (BKEP) EPS Estimated At $-0.13

Blueknight Energy Partners, L.P. (BKEP) EPS Estimated At $-0.13

Investors sentiment increased to 1 in Q3 2018. Its up 0.08, from 0.92 in 2018Q2. It increased, as 6 investors sold Blueknight Energy Partners, L.P. shares while 6 reduced holdings. 7 funds opened positions while 5 raised stakes. 12.91 million shares or 20.87% less from 16.32 million shares in 2018Q2 […]

BlackRock Capital Investment Corporation (BKCC) EPS Estimated At $0.17

Analysts expect BlackRock Capital Investment Corporation (NASDAQ:BKCC) to report $0.17 EPS on March, 6.They anticipate $0.02 EPS change or 10.53 % from last quarter’s $0.19 EPS. BKCC’s profit would be $11.85M giving it 9.18 P/E if the $0.17 EPS is correct. After having $0.18 EPS previously, BlackRock Capital Investment Corporation’s […]